Lilly, Boehringer say diabetes drug meets goals in later trials
(Reuters) - Eli Lilly and Co and Boehringer Ingelheim said on Monday that a treatment for type 2 diabetes, empagliflozin, had been shown to work in fo...
Source: http://goo.gl/mag/R6mGuah
No comments:
Post a Comment